Recent, Emerging Therapies for Connective Tissue Disease: Beyond Prednisone
- In:
Clinical Practice
• Mycophenolate mofetil has a slow onset requiring a longer trial in sclerosing disorders. If GI distress occurs, switch to mycophenolic acid.
• Therapy for Raynaud's include sildenafil, botulinum toxin, SSRIs, ACEi, ARBs, doxazosin, prazosin, pentoxifylline, topical/oral nitrates, calcium channel blockers (nifedipine>amlodipine) and behavioral modification (thick socks, smoking cessation, decrease/stop caffeine, avoid vasoconstrictors).
• In cutaneous dermatomyositis, don't forget to treat pruritis.